Categories: News

World Health Summit 2023 with 20 ministers from all over the world in Berlin from October 15-17

Press accreditation open for the world’s leading global health conference

BERLIN, Sept. 7, 2023 /PRNewswire/ — The World Health Summit 2023 from October 15-17 in Berlin will bring together the most prominent names in global health from all sectors in all regions of the world. Speakers will include government ministers from over 10 countries, renowned scientists, and high-level representatives from the private sector as well as civil society. Issues topping the agenda are the impact of climate change on health, pandemic preparedness, the global health priorities of the G7/G20 nations, digital technologies for global health, the 75th anniversary of WHO, and more equitable health systems. Under the theme “A Defining Year for Global Health Action”, over 300 speakers and several thousand participants will discuss new strategies for global health and set the course for a healthier, more equitable future.

Media representatives can apply now for on-site accreditation at www.worldhealthsummit.org/media/accreditation.html

The entire program with over 60 sessions will also be available live online for free for people around the world who may not be able to attend in person at www.worldhealthsummit.org.

The World Health Summit is the world’s leading international strategic forum for global health and is in 2023 again held under the patronage of German Chancellor Olaf Scholz, French President Emmanuel Macron, and the Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus.

Press information:
www.worldhealthsummit.org/media.html

Information on WHS 2023:  
www.worldhealthsummit.org/summit.html 

Press contact:
Alida Tiekötter
communications@worldhealthsummit.org
+49(0)30450572102

View original content:https://www.prnewswire.com/news-releases/world-health-summit-2023-with-20-ministers-from-all-over-the-world-in-berlin-from-october-15-17-301920488.html

SOURCE World Health Summit

Staff

Recent Posts

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…

6 hours ago

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…

6 hours ago